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Maternally skewed transmission of traits has been
associated with genomic imprinting and oocyte-
derived mRNA. We report canine congenital eye
malformations, caused by an amino acid deletion
(K12del) near the N terminus of retinol-binding pro-
tein (RBP4). The disease is only expressed when
both dam and offspring are deletion homozygotes.
RBP carries vitamin A (retinol) from hepatic stores
to peripheral tissues, including the placenta and
developing eye, where it is required to synthesize
retinoic acid. Gestational vitamin A deficiency is
a known risk factor for ocular birth defects. The
K12del mutation disrupts RBP folding in vivo,
decreasing its secretion from hepatocytes to serum.
The maternal penetrance effect arises from an
impairment in the sequential transfer of retinol across
the placenta, via RBP encoded by maternal and
fetal genomes. Our results demonstrate a mode of
recessive maternal inheritance, with a physiological
basis, and they extend previous observations on
dominant-negative RBP4 alleles in humans.
INTRODUCTION
The microphthalmia, anophthalmia, and coloboma (MAC) spec-
trum of congenital eye malformations are important causes of
childhood blindness (Hornby et al., 2000). Anophthalmia refers
to the complete absence and microphthalmia to reduced size
of the ocular globe. Colobomas are notch-like defects in the
iris, chorioretina, and/or optic nerve head that result from incom-
plete closure of the axial optic fissure during development
(Onwochei et al., 2000). MAC disease has a worldwide incidence
of 1 per 5,300 live births (Morrison et al., 2002). Most cases are
isolated, with defects limited to the eye, but in one-third of pa-
tients the eyemalformations occur as part of a syndrome (Verma
and Fitzpatrick, 2007). Potential mechanisms include primaryCell
This is an open access article undfailure of optic vesicle growth, optic cup invagination or lens
induction, or secondary degeneration of optic anlagen in utero
(Graw, 2003). In most cases, the etiology is unknown. Recent
reports implicate SOX2, OTX2, STRA6, and PAX6 (Fantes
et al., 2003; Ragge et al., 2005; Pasutto et al., 2007; Glaser
et al., 1994), with dominant SOX2 loss-of-function alleles being
the most common single-gene defect (Gerth-Kahlert et al.,
2013). Apart from gene mutations, various environmental risk
factors have been reported for human MAC disease, most
notably vitamin A deficiency (VAD) (Hornby et al., 2002). Vitamin
A (retinol) is a substrate for synthesis of retinoic acid (RA), a
potent paracrine-signaling molecule needed for proper develop-
ment of the vertebrate eye and other tissues (Hale, 1935; See
and Clagett-Dame, 2009). The eye is most sensitive among
organs to reduced RA levels during embryogenesis.
In recent years, the domestic dog has emerged as a powerful
model for study of simple and complex mammalian traits, due
to its unique genetic architecture and abundant genomic tools
(Lindblad-Toh et al., 2005). The canine eye more closely resem-
bles the human eye, anatomically and physiologically, than do
mouse or rabbit eyes and spontaneous hereditary eye diseases
are common (Vaquer et al., 2013). Microphthalmia has been re-
ported in several dogbreeds, including Irish soft-coatedwheaten
terriers (ISCWTs), in which microphthalmia, retinal coloboma,
hypoplasia of the choroid, and severe visceral malformations
were reported (Van der Woerdt et al., 1995). The ocular pheno-
types resemble the most severe features of collie eye anomaly
(CEA), but they are genetically distinct (Parker et al., 2007).
In this study, we report a retinol-binding protein (RBP4) defect
in a canine developmental eye disease; characterize its clinical,
genetic, and biochemical properties; and consider the physio-
logical implications of this unique recessivematernal penetrance
effect.
RESULTS
Microphthalmia and Other Developmental Eye Defects
in ISCWTs
An ISCWT breeder in Finland contacted us in 2011 after noticing
abnormally small eyes in three pups in a litter of six. Eye examsReports 23, 2643–2652, May 29, 2018 ª 2018 The Author(s). 2643
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Autosomal Recessive Micro-
phthalmia in ISCWT Dogs
(A) External eye phenotype, showing micro-
phthalmia.
(B) Pedigree diagramshowing lineage relationships
among diseased dogs, clinical eye findings, RBP4
genotypes, and the maternal penetrance effect.
Phenotypes and confirmedDNAgenotypes (n = 67)
are indicated by inner and outer symbols, respec-
tively, as described in the inset legend. Dogs
included in the GWAS are highlighted in yellow
(12 cases and 17 controls). All 17 microphthalmic
dogs (- C) and their dams are RBP4 deletion
homozygotes (del/del). One deletion homozygote
with a homozygous dam had eyes of normal size,
with chorioretinal hypoplasia. Ten dogs without
microphthalmia (, B) were also genotyped as
homozygous (del/del), but they had heterozygous
(del/+, n = 9) or untyped (del/, n = 1) dams.
See also Figure S2 and Table S1.before 10 weeks of age revealed bilateral microphthalmia with
scleral folding, chorioretinal hypoplasia, and retinal colobomas
in the affected dogs (Figure 1A; Table S1). A second affected
litter of eight was subsequently born in Poland. Eye exams
confirmed bilateral microphthalmia in six pups and chorioretinal
hypoplasia in one pup and unilateral retinal coloboma. Then
2 years later, another litter was born to the same dam with a
different sire. Three of eight pups had bilateral microphthalmia,
chorioretinal hypoplasia, and retinal colobomas; one had a uni-
lateral flat optic nerve head; and four were unaffected. In a fourth
litter, born in the Czech Republic, five of six pups had bilateral
microphthalmia and one had chorioretinal hypoplasia. The dam
and sire of each litter had normal eye exams. The dams were
fed high-quality commercial chow and no abnormalities were
noted during gestation.
For genetic analysis, our inclusion criteria for subject dogs
(cases) was bilateral microphthalmia (n = 17, with 11 males
and 6 females). Normal control dogs (n = 23), ascertained from
the same large ISCWT pedigree, were carefully examined by a
veterinary ophthalmologist before 10 weeks of age, as tapetal
pigmentation in older dogs can mask milder forms of chorioreti-
nal hypoplasia (Bjerkås, 1991).
Genetic Analysis Reveals an In-Frame 3-bp Deletion
in RBP4
The four affected litters are related in a single pedigree, with
a transmission pattern suggesting an autosomal recessive
mode of inheritance as several affected pups in different litters
were born to unaffected parents (Figure 1B). To map the disease
locus, we performed a genome-wide association study (GWAS)
with 12 cases, 17 controls, and 172,963 SNPmarkers. Statistical
analysis of genotype data by PLINK indicated a 15.7-Mb critical
region on canine chromosome 28 (praw = 8.043 10
9, pgenome =
1.00 3 105), spanning nucleotides 287,714 to 16,036,936 bp
(CanFam 3.1), in which all cases shared a single homozygous
haplotype block (Figure 2). The localization was confirmed
by GenABEL analysis, using a full genomic kinship matrix to
adjust population structure and mixed model approximation
(Figure S1).2644 Cell Reports 23, 2643–2652, May 29, 2018To identify the causative variant, we sequenced the entire
genome of one affected dog. A total of 470,800,949 reads
were collected, of which 98.7% were mapped to the reference
genome (CanFam 3.1). The mean read depth was 28.73 and
98.3% of mapped reads had >103 coverage. We identified
6,497,411 homozygous variants compared to the reference
sequence, and 37,291 of these remained after filtering variants
from 342 control dogs of breeds that lack the studied phenotype
(Table S2). Among the remaining variants, 81 were exonic, but
only one of these was located in the CFA28 critical region. This
variant is a 3-bp deletion (c.282_284del) in the gene encoding
RBP4 gene, resulting in the loss of a single lysine (AAG codon)
near the RBP amino terminus (p.K30del), in a charged segment
preceding the lipocalin b-barrel domain (Figure 3). This is the
12th amino acid in the mature protein (K12del), after cleavage
of the signal peptide, and it is highly conserved among
vertebrates. The secreted portions of dog and human RBP are
the same length (183 amino acids) and have 94.5% sequence
identity.
Maternal Inheritance Effect
To confirm that the RBP4 variant segregates with the disease
trait, we genotyped all available dogs (n = 46) from affected litters
and their close relatives (Figure 1B). As expected, the 17 cases
were homozygous for the K12 deletion, and the 23 clinically
confirmed controls were wild-type (WT) (+/+) or heterozygous
(del/+). However, the three dams of the four affected litters
were also homozygous for the deletion yet had normal eye
exams. Notably, their dams were heterozygous. These results
suggest a recessive mode of inheritance with reduced pene-
trance and a potential maternal genotype effect (Figure 1B).
To further evaluate the maternal effect on inheritance, we gen-
otyped all available ISCWT samples in our biobank (n = 248). This
analysis revealed 185WT dogs (74.6%), 55 carriers (22.2%), and
8 homozygotes (3.2%), consistent with Hardy-Weinberg equilib-
rium (p = 0.32, c2 test, df = 2). Among these eight new K12del
homozygotes, three had normal fundus eye exams as adults,
four had normal general exams with no clinically apparent
microphthalmia, and one suffered from chorioretinal hypoplasia.
Figure 2. Mapping the ISCWT Microphthal-
mia Locus
(A) Summary of GWAS data. Manhattan plot of a
genome-wide case-control association analysis,
with 12 cases and 17 controls, shows localization
of microphthalmia trait on CFA28, with a corrected
probability value Pgenome = 1.00 3 10
5.
(B) Genotype data showing a shared haplotype
block in microphthalmic dogs (cases). Each row
represents a single animal, with the genotypes at
each SNP locus (columns) indicated by dark (AA),
intermediate (AB), or light (BB) shading, in relation
to the affected haplotype (BB). Every affected
dog is homozygous within this segment. The
15.7-Mb critical region spans approximately 38%
of CFA28, near the centromere, and it is delimited
by SNP markers BICF2S23220161 (centromeric)
and BICF2S23334005 (telomeric).
See also Figure S1.Maternal genotypes are known for seven of these dogs; in each
case, the dam was heterozygous, except for the dog with cho-
rioretinal hypoplasia, whose dam was an RBP4 deletion homo-
zygote. These data demonstrate a strikingmaternal transmission
effect on inheritance (Table 1; p < 104, Fisher’s exact test,
df = 1). Accordingly, the microphthalmia trait is manifest only
when both dam and offspring are homozygous for the deletion
(17/18). If the dam is heterozygous, her homozygous offspring
have grossly normal eye anatomy (9/9). The penetrance of the
microphthalmia trait in del/del dogs is thus 94% or 0%, respec-
tively, depending on the dam genotype.
Because some human RBP4 alleles have dominant pheno-
types (Chou et al., 2015), we investigated the clinical status of
del/+ carriers in detail. Among 71 heterozygotes in our study
cohort, 46 had thorough eye exams. Dam genotypes, deter-
mined for 37 of these 46 carriers, were as follows: 14 homozy-
gous (del/del), 11 heterozygous (del/+), and 12 WT (+/+). Two
carriers did have CEA-like findings (chorioretinal hypoplasia)
but no microphthalmia. These 2 dogs were littermates of
affected pups (Figure 1B) and their dams were deletion homozy-
gotes. All other del/+ carriers examined were normal. In partic-
ular, 8 of these 12 unaffected carriers born to del/del dams
had fundus exams before 10 weeks of age to reliably assess
choroidal anatomy (Bjerkås, 1991).
To exclude mild retinal pathology in dogs born to heterozy-
gous dams, we performed OCT (optical coherence tomography)
imaging on 11 ISCWTs with different genotypes (3 +/+, 4 del/+,
and 4 del/del). Whole retinal thickness (WRT) and photoreceptor
layer thickness (PRT) were within normal limits in every dog,
and no statistically significant difference was found between
genotype groups (Figure S2). Thus, for offspring to manifest
eye disease, the dam must be an RBP4 deletion homozygote,
with phenotypic severity depending on the offspring genotype
(p < 106, Fisher’s exact test, df = 1). Deletion homozygotes
had microphthalmia with nearly complete penetrance (17/18)
or chorioretinal hypoplasia (1/18), whereas heterozygotes had
a milder condition, such as chorioretinal hypoplasia, with low
penetrance (2/14).Dose-Dependent Decrease in Serum RBP and Vitamin A
Levels
RBP circulates in blood and transports vitamin A from hepatic
stores to peripheral tissues, such as the developing eye. In prin-
ciple, the K12 deletion, near the ligand-binding domain (Figures
3C–3E) may disrupt RBP folding, stability, or secretion; retinol-
binding activity; and/or interaction with the STRA6 receptor. To
investigate stability and retinol-binding effects, we measured
serum RBP and vitamin A levels in 17 adult ISCWTs, including
8 deletion homozygotes (3 withmicrophthalmia), 6 del/+ carriers,
and 3 WT dogs (Figure 4). Serum albumin and total protein were
assayed in parallel as a control. RBP levels were assessed by
western analysis, following denaturing gel electrophoresis
(SDS-PAGE) under reducing conditions, and were normalized
to wild-type. Relative RBP levels (±SD) were roughly halved in
heterozygotes (0.66 ± 0.20) and greatly reduced in homozygotes
(0.24 ± 0.10) compared to WT dogs (1.00 ± 0.39). The mutant
protein is thus poorly secreted or rapidly cleared from the
bloodstream.
To assess the structure of circulating canine K12del RBP,
we performed western analysis on serum samples under non-
reducing conditions (Figure 4B). To maximize exposure of epi-
topes in native globular RBP after electrophoresis, SDS-PAGE
gels were treated with b-mercaptoethanol (bME) before transfer
(Zetterström et al., 2007). In these experiments, the K12del pro-
teinmigrated as an apparent homodimer (42 kDa) in homozygote
sera, with little or no monomeric RBP. Presumably, the K12del
RBP variant folds abnormally in the hepatic endoplasmic reticu-
lum (ER) of mutant dogs, leading to the formation of intermolec-
ular disulfide bonds, which allows progression of the mutant
RBP to the Golgi compartment (Kaji and Lodish, 1993). The
mutant dimers were more antigenic than wild-type (WT) mono-
mers in non-reducing western blots, reflecting their partially
unfolded status in vivo (Figure S3). Consequently, the dimer
fraction of serum RBP was determined following in-gel reduc-
tion. In heterozygous dogs, the ratio of dimers to monomers
was 0.23 ± 0.04, consistent with the overall decrease in serum
RBP (Figure 4A). These data, and the linear relationship betweenCell Reports 23, 2643–2652, May 29, 2018 2645
Figure 3. Pathogenic RBP4 Deletion
(A) p.K30del mutation. Genomic map shows the solitary coding variant iden-
tified in the critical region by whole genome sequencing, a 3-bp deletion in
exon 2 that removes lysine codon 30 from the RBP precursor. This residue
corresponds to K12 in the mature polypeptide, after signal peptide cleavage.
Coding (dark blue) and UTR sequences (light blue) are indicated.
(B) Sanger chromatograms showing the DNA sequence of PCR products
spanning the RBP4 deletion in wild-type (WT), carrier, and affected dogs. The
deletion removes one of two tandem lysine codons (AAG).
(C) Linear diagram of RBP showing the signal peptide (SS); 8 antiparallel
b sheets (A–H, blue arrows), which form the ligand barrel; 2 short a-helical
segments (cyan coils); 3 cysteine disulfide bonds, which stabilize the tertiary
structure; and the mutated K12 residue.
(D) Alignment of vertebrate RBP sequences showing evolutionary conserva-
tion of K12 among eutherians. The signal peptide (red), tandem lysines (K12-
K13, blue), and disulfide-linked cysteine (C4, green) are indicated. The N-ter-
minal segment preceding the b-barrel (10 of 21 residues) is highly charged.
(E) Tertiary structure of canine RBP (ribbon views), modeled from human apo
(1RBP) and holo (1BRQ) RBP X-ray data (Cowan et al., 1990; Zanotti et al.,
1993a, 1993b), showing K12 near the N terminus, within an a-helical region. By
shortening this segment, K12del may limit apposition of C4 and C160 side
groups in the ER, preventing formation of one disulfide bond in vivo and,
consequently, destabilizing the protein.
See also Table S2.
Table 1. Eye Phenotypes and Maternal Genotypes of RBP4
p.K12del Homozygous Offspring
Dam Genotype
Microphthalmia in del/del Offspring
Present Absent
Homozygote (del/del) 17 1a
Carrier (del/+) 0 9
Unknown (del/–) 0 1
Total 17 11
Sire genotypes were del/+ for 12 microphthalmic dogs and del/– for
5 dogs. For non-microphthalmic dogs, sire genotypes were del/+ for
7 dogs and del/– for 4 dogs. The skewed distribution of maternal geno-
types in this retrospective analysis is highly significant (p < 106, Fisher’s
exact test, df = 1).
aChorioretinal hypoplasia with normal globe size.genotype and total RBP levels (Figure 4C), indicate that the
K12del protein does not significantly dimerize with WT RBP or
interfere with its secretion in vivo.
Vitamin A levels (±SD) were severely reduced in all deletion
homozygotes (0.06 ± 0.02 mg/L), compared to WT (0.55 ±2646 Cell Reports 23, 2643–2652, May 29, 20180.20 mg/L) and the normal canine reference range (0.3–
1.3 mg/L), regardless of phenotype (p < 0.0001; Figures 4C
and 4D). Vitamin A levels in carriers were 0.34 ± 0.13mg/L, below
(n = 2, 0.19 and 0.21 mg/L) or marginally within (n = 4, 0.31–
0.51 mg/L) the reference range. Serum albumin and total protein
were normal in 16 of 17 dogs but reduced in one affected dog
(Table S1). The vitamin A levels were thus directly correlated
with immunoreactive RBP across genotypes (r2 = 0.88; Fig-
ure 4D). Collectively, these results suggest that the K12del muta-
tion destabilizes RBP in vivo, preventingmobilization of vitamin A
from maternal liver stores to the embryo. Moreover, misfolded
K12del dimers are unlikely to interact effectively with retinol,
transthyretin, or STRA6 in vivo, given the behavior of human
pathogenic RBP4 missense alleles in vitro (Chou et al., 2015)
and steric constraints evident in the X-ray structure of holo
RBP-TTR4 (Berni and Formelli, 1992). However, formally the pos-
sibility of the direct binding of the K12del mutant to STRA6 could
be tested, as described previously (Chou et al., 2015).
Mutant RBP dimers may be cleared from the bloodstream by
megalin (LRP2) or other receptors (Wyatt et al., 2011), but they
are unlikely to enter the urine in the absence of renal damage.
In normal mammals, holo RBP circulates bound to TTR tetra-
mers, which increases its effective molecular weight (>75 kDa)
and prevents filtration in the kidneys (Vahlquist et al., 1973). To
test this hypothesis, we measured RBP levels in urine (uRBP)
samples from the 17 genotyped dogs whose serum data are
described above. We detected uRBP in only two samples, a
K12del homozygote and a K12del/+ carrier, at approximately
1/20th the mean WT serum level (Figure S4). These two dogs
are likely to have impaired renal function, as total urinary protein
was also elevated (data not shown).
The K12del Mutation Impairs Secretion of RBP
Monomers from Cultured HeLa Cells
As a further test of K12del effects, we compared the abundance
and structure of RBP polypeptides secreted into the conditioned
media (CMs) and retained in the cytoplasm of transfected HeLa
cells and their interactions with transthyretin (Figure 5). Plasmid
constructs expressing K12del or WT canine RBP or orthologous
human mutants (K12del or E13del) were generated (Table S3)
and tested in parallel, with human WT and mutant controls,
Figure 4. SerumRBP and Vitamin A Analysis
(A) ECLwestern blot (reducing conditions) showing
dog RBP monomers (21 kDa) with human HARBP
(22 kDa) as a positive control (HeLa-CM). The
higher MW signal is dog IgG (150 kDa), which
cross-reacts with the secondary reagent (donkey
anti-rabbit IgG) and is relatively resistant to DTT
(Singh and Whitesides, 1994).
(B) Parallel blot (non-reducing conditions) showing
RBP monomers (WT) and homodimers (K12del
mutant). Both species are present in heterozy-
gotes, in roughly a 4:1 molar ratio.
(C) Histograms comparing immunoreactive
serum RBP and vitamin A (mean ± SD) versus
genotype. There is a linear dosage relation-
ship, with heterozygotes having an intermediate
level of RBP (0.66 ± 0.20) that is close to the
arithmetic mean of del/del and +/+ samples
(0.62 ± 0.22).
(D) Scatterplot comparing serum vitamin A
(mg/mL, ordinate) and relative RBP (abscissa) for
all samples, including WT (black), HET (gray),
and DEL (white) dogs with normal eyes (circles)
and microphthalmic DEL dogs (white squares).
The values are well correlated (p < 0.0001,
r2 = 0.88); however, the regression line is shifted
rightward from the origin, indicating that the
K12del protein binds less retinol in vivo than WT. The homozygous DEL samples have similar RBP and vitamin A levels, regardless of phenotype (one-way
ANOVA, p = 0.18 for RBP and p = 0.45 for vitamin A, comparing 5 normal and 3 microphthalmic dogs).
See also Tables S1 and S3.including stable (A55T) and unstable (G75D and I41N) patho-
genic isoforms (Chou et al., 2015). Western analysis of CMs
and cell lysates, performed under reducing and non-reducing
conditions (±bME), showed that secretion of K12del (and
E13del) mutants was significantly altered, with a striking
predominance of dimers. The dimer fractions for K12del and
WT canine RBP in CMs were 0.89 and 0.007, respectively
(Figure 5A, left), whereas the total amount of RBP secreted
was similar (Figure 5A, right). Likewise, human E13del, K12del,
G75D, and I41N mutants were secreted into CMs as >85%
dimers, compared to <1% for A55T and WT controls, and
secretion of human E13del and K12del was diminished. There
were at least two distinct RBP dimer species in CMs, indicated
by closely migrating 42-kDa products in the non-reducing west-
ern blot (Figure 5A). This conformational heterogeneity is likely to
reflect the formation of intermolecular disulfide bonds between
different cysteine pairs, with a variable degree of compactness.
In a previous study of RBP oxidative folding in HepG2 cells
in the presence of DTT, an ensemble of folding intermediates
was similarly identified by their heterodisperse migration in
non-reducing gels (Kaji and Lodish, 1993).
Western analyses of cell lysates± bME further showed that dog
K12del and human E13del mutant RBPs accumulated in cyto-
plasm,withnormalized lysate-to-CMratiosof 1.5and6.0, respec-
tively, compared to WT (ratio = 1.0) (Figure 5C, right). The abun-
dance of RBP monomers in mutant cell lysates was notable,
given their paucity in CMs, and these proteins migrated as R2
different species (Figure 5C, left). Monomers comprise >50% of
RBP in lysates but <15%of RBP secreted into CMs by HeLa cells
expressing dog K12del or human E13del mutants. In contrast,monomers comprise >99% of WT RBP in cell lysates and CMs.
Together, these data suggest that the ISCWT mutation disrupts
the kinetics of RBP folding in vivo and slows secretion, with itera-
tive cycles of oxidative refolding or dimerization in the ER as a
likely rate-limiting step (Ruggiano et al., 2014).
To further assess mutant RBPs, we tested their interaction
with bovine transthyretin (TTR) in CM by immunoprecipitation
(Figure 5B). In these experiments, WT and stable mutant RBPs
bound TTR, but K12del and other mutants did not. The low levels
of serum RBP in mutant dogs may thus arise from decreased
hepatic secretion and increased renal or systemic clearance of
abnormal RBP dimers.
K12del Protein Can Fold as a Monomer and Bind
Vitamin A In Vitro
To evaluate how the mutation alters RBP structure more pre-
cisely, we expressed recombinant WT and K12del proteins in
E. coli strain Origami B(DE3), which has an oxidizing cytoplasmic
environment allowing disulfide bond formation, and we used gel
filtration (size exclusion chromatography [SEC]) as the final puri-
fication step (Kawaguchi et al., 2013). WT and K12del RBPs
eluted in the same fraction (volume 92 mL) in parallel columns,
indicating that both proteins have the same overall size and
monomeric form (Figure S5). The chromatograms also showed
small dimeric (elution volume 82 mL) and multimeric peaks,
which were similar for both variants. The extent of aggregation
depended on the concentration of purified proteins: both WT
and K12del RBPs were monomeric in concentrations under
0.8 mM but aggregated at higher concentrations, as indicated
by an increased nuclear magnetic resonance (NMR) line width.Cell Reports 23, 2643–2652, May 29, 2018 2647
Figure 5. RBP Secretion and Transthyretin
Binding In Vitro
(A–C) LI-COR western analysis of (A) CM, (B) im-
munoprecipitates (IP) of CMs, and (C) radio-
immunoprecipitation assay buffer (RIPA) lysates
from transfected HeLa cells expressing dog (WT
and K12del) or human (WT, K12del, E13del, A55T,
G75D, and I47N) HARBPs, detected using anti-HA
antibody. In (A) and (B), parallel gels were elec-
trophoresed under reducing (+bME, right) or non-
reducing conditions (no bME, left), with bovine TTR
and human a-tubulin as CM and lysate loading
controls, respectively.
(A) Recombinant HARBPs are secreted as dimers
or higher multimers (K12del in both species; hu-
man E13del, G75D, and I41N) and monomers (WT
in both species, human A55T). The K12del dimers
secreted by HeLa cells in vitro appear similar
to RBP dimers secreted by mutant dogs in vivo,
and presumably they reflect the exposure of
unpaired cysteines, which persist after intra-
molecular oxidative folding. The A55T, G75D, and
I41N proteins behave as previously reported (Chou
et al., 2015).
(B) The RBP profiles of transfected cell lysates
and CMs generally correspond; however, mutant
monomers are notably more abundant (>50%) in
cell lysates than in CMs. These abnormal RBPs are
presumably retained in the ER and secreted
following dimerization.
(C) Co-immunoprecipitation showing that only
WT and stable A55T mutant HARBPs interact with
bovine TTR present in the CMs.
See also Figure S3.A heteronuclear single quantum coherence (15N-HSQC)
spectra of WT and K12del clearly showed that both variants
folded in vitro and that the deletion did not significantly disrupt
the overall structural integrity of RBP (Figures 6A–6D). As
expected, chemical shift perturbations (CSPs) between WT
and K12del were observed for residues that were spatially
close to the deletion site (K12). Chemical shift of cysteine
b-carbons is a reliable indicator of cysteine oxidation state
(Sharma and Rajarathnam, 2000; Mobli and King, 2010).
The observed cysteine b-carbon (Cb) chemical shift
values for residues C4 and C160 were 38.6 and 40.7 ppm,
respectively, which are typical values for oxidized cysteine
residue. The corresponding chemical shift values for reduced
cysteines are 28.3 ± 2.2 ppm (Sharma and Rajarathnam,
2000). These data strongly suggest that C4 and C160 are2648 Cell Reports 23, 2643–2652, May 29, 2018oxidized and establish a disulfide bond
within the recombinant K12del protein,
similar to WT.
We also compared retinol binding of
WT and K12del proteins using NMR spec-
troscopy. Retinol induced large CSPs
for some residues in the 15N-HSQC
spectrum of RBP, making their identifica-
tion ambiguous, so we reassigned all
chemical shifts for retinol-bound RBP(Greene et al., 2006). In this analysis, an equimolar ratio of
vitamin A induced CSPs in the same residues of both RBP
variants (Figures 6E and 6F). The K12 deletion thus does not
alter the intrinsic retinol-binding mechanism or affinity, as WT
and K12del RBPs synthesized in vitro-bound vitamin A similarly
under the conditions studied.
Thus, whereas K12del RBP produced by canine hepato-
cytes in vivo or HeLa cells in culture is misfolded and secreted
as abnormal dimers with little or no retinol cargo, NMR data
clearly show that K12del RBP synthesized in a heterologous
E. coli environment, outside the mammalian ER lumen and
Golgi network, can fold properly at 16C and form intra-
molecular disulfide bridges similar to WT RBP and bind to
vitamin A with the same interface and similar affinity as WT
RBP (Figure 6F).
Figure 6. NMR Analysis of RBP Folding and
Retinol Binding In Vitro
(A and B) 15N-HSQC spectra of (A) apo WT RBP
(red) and (B) apo K12del RBP (blue) produced in
Origami B(DE3) E. coli. Both spectra are charac-
teristic for native folded proteins.
(C) Enlarged view of critical region (black box
in A and B) with WT and K12del spectra overlaid
for comparison. Large chemical shift perturbations
(CSPs) observed for I107, K17, and R5 are denoted
by black arrows.
(D) Schematic ribbon diagram of WT canine
holo RBP showing the largest chemical shifts
changes caused by the K12del mutation (cyan).
The K12 side chain (blue), disulfide bridges (green),
C4-C160 disulfide bridge (red arrow), and all-
trans retinol (vitamin A, magenta) are marked. The
structure is modeled from human RBP coordinates
obtained from PDB: 1BRP (Zanotti et al., 1993b;
Mobli and King, 2010).
(E) Representative region of 15N-HSQC spectra
showing vitamin A binding to WT RBP (left panel,
apo [red] versus holo [magenta]) and K12del RBP
(right panel, apo [blue] versus holo [green]). The
congruent patterns suggest that the retinol contact
sites and binding affinities of WT and K12del RBP
are similar.
(F) Ribbon diagram showing the largest CSPs due
to vitamin A binding (yellow) in both variants, with
K12 and disulfide bridges marked as in (D).
See also Figure S5.DISCUSSION
In this study, we demonstrate that deletion of a single amino
acid from the canine serum RBP causes severe congenital
eye malformations in ISCWTs using segregation, clinical, and
molecular data. The phenotype is transmitted as an autosomal
recessive trait with penetrance determined by the maternal
genotype. This unusual inheritance pattern is caused by the
disruption of vitamin A transport from maternal hepatic stores
to the developing fetal eye, in situations where functional
RBP is absent on both sides of the placenta. In WT mammals,
RBP transfers fat-soluble retinol bidirectionally, to (influx) and
from (efflux) cells at the materno-fetal interface, respectively,
via the STRA6 receptor (Kawaguchi et al., 2012). The resulting
deficiency of vitamin A in affected ISCWT embryos presumably
limits RA signaling during critical stages of eye development.
Two hits, maternal and fetal homozygous RBP4 mutations,
are evidently needed to reduce vitamin A levels below the
threshold for phenotypic expression in offspring. A genetically
similar recessive maternal effect has been noted in Rbp4-
knockout mice, but only when the dam is maintained on a
VAD diet after conception (Quadro et al., 2005), and it is pre-Cell Rdicted for human RBP4-null alleles
(Biesalski et al., 1999; Khan et al., 2017)
in the unlikely scenario where both
mother and child are homozyotes.
Maternally skewed expression of RBP4
defects has been reported in humanMAC pedigrees, but with dominant transmission and incom-
plete penetrance (Chou et al., 2015).
The difference in severity of Rbp4 and Stra6 phenotypes
between species has been puzzling. In particular, the relatively
mild developmental effects observed in mutant mice (Quadro
et al., 1999) compared to humans (Pasutto et al., 2007; Chou
et al., 2015) has led some to assert that the RBP-STRA6 pathway
is relatively unimportant for vitamin A homeostasis, apart from
retinal physiology (Berry et al., 2013). These discordant pheno-
typesmay reflect differences amongmammals in placental anat-
omy and function, relative dependence on tonic RBP-mediated
vitamin A transport versus postprandial delivery of retinyl ester
in chylomicron particles (D’Ambrosio et al., 2011), or direct trans-
fer of vitamin A via uterine lumenal secretions (Suire et al., 2001).
The canine model confirms the importance of RBP and STRA6
for mobilizing vitamin A during fetal development and further
illuminates this pathway. Notably, the ISCWT phenotype
manifests without dietary restriction. While the exact cellular
interface for materno-fetal vitamin A transfer is poorly defined
(Marceau et al., 2007), the placentae of rodents and primates
are hemochorial, with direct contact between maternal blood
and trophoblast layers, whereas carnivores such as dogs haveeports 23, 2643–2652, May 29, 2018 2649
endotheliochorial placentae, with greater histocompartmental
separation between maternal and fetal circulation (Wooding
and Burton, 2008).
To fully understand the molecular effects of the ISCWT muta-
tion, we analyzed K12del RBP4 at three levels: as recombinant
protein purified from bacteria, as protein secreted in the CMs
of cultured HeLa cells, and as canine sera in vivo. When
K12del RBP is expressed in the Origami B(DE3) E. coli strain un-
der favorable conditions at 16C, in an oxidizing cytoplasm
created by double thioredoxin (trxB) and glutaredoxin reductase
(gor) mutations, it folds correctly, forms internal disulfide bonds,
and binds retinol similar toWT, with altered residue positions but
no obvious molecular strain. In contrast, when K12del RBP is ex-
pressed by eukaryotic cells, both canine hepatocytes and HeLa
cervical carcinoma cells, it misfolds, such that one or more inter-
nal disulfide bonds does not form within the ER lumen, during or
after translation and signal peptide cleavage, leaving unpaired
cysteines. The misfolded polypeptides with exposed thiol
groups are presumably retained and destroyed via the ERAD
(ER-associated protein degradation) pathway, following abortive
refolding cycles (Ruggiano et al., 2014), or they are linked to
other misfolded RBPs via intermolecular cysteine disulfide
bridge(s), passed by ER quality control (Vembar and Brodsky,
2008), and secreted as homodimers. During oxidative folding
of WT RBP in ER microsomes, facilitated by multiple chaper-
ones, the C120-C129 disulfide bond forms first and is most
critical to stability; the large C4-C160 and C70-C174 loops
form subsequently (Selvaraj et al., 2008). Assuming K12del and
WT alleles are transcribed and translated with equal efficiency,
our quantitative western analyses of dog sera suggest that
most K12del protein is degraded prior to secretion or rapidly
cleared from the bloodstream.
These disparate results are instructive. K12del foldingmust be
thermodynamically favored, as it occurs readily, in a heterolo-
gous E. coli environment. However, the folding funnel must
have altered topology, compared to WT (Dill and Chan, 1997).
As noted by Cowan et al. in their original RBP X-ray crystal
structure report, ‘‘residues which contribute to the formation
of the retinol-containing barrel start at residue 12. The methylene
groups of the lysine side chain of K12 help close off the barrel... ’’
(Cowan et al., 1990). Consequently, K12del folding within the
mammalian ER lumen may be kinetically compromised; it pro-
ceeds too slowly to escape the ERAD pathway and allow secre-
tion of K12del RBP monomers. Misfolding occurs in K12del
mutant dogs in vivo, despite the presence of ample hepatic
retinol, which acts as amolecular chaperone to stimulate correct
RBP folding and co-secretion of the holo RBP-TTR complex
(Kawaguchi et al., 2013; Bellovino et al., 1996).
We believe the eukaryotic data best explain the clinical find-
ings and are most relevant and that the K12del mutation acts
as a null allele. Indeed, WT apo RBP, expressed in reducing
E. coli strains (e.g., BL21) and oxidized randomly in vitro with
glutathione (GSSG/GSH), exists as an ensemble of conformers,
including several products with non-native disulfide bonds, and
it must be further purified for biochemical assays (Kawaguchi
et al., 2013). Moreover, an engineered RBP expressed in
E. coliwith six cysteine-to-serine substitutions can fold correctly
in vitro and bind vitamin A in the absence of stabilizing disulfide2650 Cell Reports 23, 2643–2652, May 29, 2018bonds (Reznik et al., 2003), whereas similar mutant RBPs
expressed in isolated dog microsomes cannot (Selvaraj et al.,
2008). Finally, in a previous study of recessive human RBP4
alleles, G75D and I41N proteins expressed in E. coli were
reported to fold correctly, bind TTR and retinol, with reduced sta-
bility of the holo RBP complex (Folli et al., 2005), yet these pro-
teins were undetectable in patient serum (Biesalski et al., 1999)
and are secreted as aggregates from transfected HeLa cells
(Chou et al., 2015).
Together, our findings highlight a unique type of autosomal
recessive inheritance in mammals, a maternal effect on pene-
trance with a physiological basis in nutrient transport across
the placenta. Our study establishes a large animal model to
investigate RBP4 function and pathology and enables novel
treatment options.
EXPERIMENTAL PROCEDURES
Further details and an outline of resources used in this work can be found in the
Supplemental Experimental Procedures.
The Canine Study Cohort
The study cohort was established from privately owned purebred ISCWTs
with their owners’ consent and included 17 cases (11 males and 6 females)
from 4 closely related litters and 23 controls (9 males and 14 females). All
dogs were 6–10 weeks old at the time of clinical examinations, as described
in the Supplemental Experimental Procedures. DNA analysis was also
performed on 254 ISCWTs (111 males and 143 females) of different ages to
evaluate the carrier frequency of the mutation in the breed. Sample collection
and clinical studies were performed with approval from the Animal Ethical
Committee of the County Administrative Board for Southern Finland (ESAVI/
6054/04.10.03/2012), and all experiments were performed in accordance
with relevant guidelines and regulations.
Genetic Analyses
A GWAS and whole-genome sequencing were performed to map the
disease locus and to identify the causative variant followed by a popula-
tion screening by Sanger sequencing, as described in the Supplemental
Experimental Procedures.
Biochemical Studies
Serum and urine samples for RBP and vitamin A assays were collected from
17 dogs and vitamin A was measured. To assess the protein structure and
function immunoblot analysis of native canine RBPs and recombinant HARBPs
expressed by cultured HeLa cells as well as structural NMR studies in E. coli
were performed. Details of the biochemical studies are described in the
Supplemental Experimental Procedures.
Statistical Methods
Parametric tests and exact n values are provided in the respective
Experimental Procedures and Results sections. Statistical significance was
evaluated in relation to a threshold p value of 0.05 (for GWAS after 100,000
permutations).
DATA AND SOFTWARE AVAILABILITY
The accession number for thewhole-genomesequencingdata fromanaffected
ISCWT reported in this paper is NCBI Short Read Archive: SRP126148.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.04.118.
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